Saturday, February 25, 2023 6:46:37 AM
yes Im outraged.
Linda and Les saw an opportunity to build their second CDMO financed by NWBO shareholders and they took it, putting the submission of approval on hold. I do believe that in the end, they will submit and DCVAX will get approved. I they would not and just start building other private CDMOs financed by NWBO shareholders they will spend the rest of their lives in courtrooms.
Im an NWBO long, although there are those that do not believe that. After 6 years of being invested in NWBO Im now at break even. I could and should have been invested in other companies with honest management.
I could have lived with a failed trial. Thats all in the game when investing in biotech. But being stiffed by two old greedy incompetent grifters. Im outraged.
Linda and Les saw an opportunity to build their second CDMO financed by NWBO shareholders and they took it, putting the submission of approval on hold. I do believe that in the end, they will submit and DCVAX will get approved. I they would not and just start building other private CDMOs financed by NWBO shareholders they will spend the rest of their lives in courtrooms.
Im an NWBO long, although there are those that do not believe that. After 6 years of being invested in NWBO Im now at break even. I could and should have been invested in other companies with honest management.
I could have lived with a failed trial. Thats all in the game when investing in biotech. But being stiffed by two old greedy incompetent grifters. Im outraged.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
